Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders.
about
Resveratrol induces apoptosis of human chronic myelogenous leukemia cells in vitro through p38 and JNK-regulated H2AX phosphorylation.Novel t(5;19) Translocation in a Patient with PDGFRB Associated Chronic Leukemia: Implications for Treatment Strategy.Detection of a PDGFRB fusion in refractory CMML without eosinophilia: A case for broad spectrum tumor profiling.
P2860
Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Imatinib and tyrosine kinase i ...... myeloproliferative disorders.
@en
Imatinib and tyrosine kinase i ...... myeloproliferative disorders.
@nl
type
label
Imatinib and tyrosine kinase i ...... myeloproliferative disorders.
@en
Imatinib and tyrosine kinase i ...... myeloproliferative disorders.
@nl
prefLabel
Imatinib and tyrosine kinase i ...... myeloproliferative disorders.
@en
Imatinib and tyrosine kinase i ...... myeloproliferative disorders.
@nl
P2860
P1476
Imatinib and tyrosine kinase i ...... e myeloproliferative disorders
@en
P2093
Ruben A Mesa
P2860
P304
P577
2007-06-01T00:00:00Z